L
Market Data
$4.85−$0.76 (−13.55%)
LRMR · Last trade
Prev Close
$5.61
Range (30d)
$4.30 – $5.42
Recent Filings
- 10-K13.2 MBLarimar Therapeutics, Inc.Mar 19, 3:41 PM ET·0001193125-26-115878
- 8-K1.1 MBLarimar Therapeutics, Inc.Mar 19, 7:04 AM ET·0001193125-26-115119
- 8-K24.9 MBLarimar Therapeutics, Inc.Mar 9, 4:08 PM ET·0001193125-26-098493
- 8-K476.9 KBLarimar Therapeutics, Inc.Feb 26, 5:48 PM ET·0001193125-26-077646
- 8-K25.3 MBLarimar Therapeutics, Inc.Feb 24, 7:02 AM ET·0001193125-26-065186
- 8-K279.1 KBLarimar Therapeutics, Inc.Jan 22, 7:00 AM ET·0001193125-26-018664
- 8-K25.1 MBLarimar Therapeutics, Inc.Jan 12, 4:18 PM ET·0001193125-26-010409
- 8-K376.2 KBLarimar Therapeutics, Inc.Dec 17, 8:00 AM ET·0001193125-25-321738
- 8-K23.9 MBLarimar Therapeutics, Inc.Nov 10, 2:01 AM ET·0001193125-25-273217
- 10-Q8.5 MBLarimar Therapeutics, Inc.Nov 5, 4:15 PM ET·0001193125-25-266969
Insiders
10- Allen Patricia LChief Financial Officer
- Atlas Venture Fund VII L P10% Owner
- Barrett PeterDirector, 10% Owner
- BEN-MAIMON CAROLEDirector, President and CEO
- Booth BruceDirector, 10% Owner
- Celano MichaelChief Financial Officer
- CHONDRIAL THERAPEUTICS HOLDINGS, LLC10% Owner
- Clayton RussellChief Medical Officer
- Daniel Thomas ODirector
- Deerfield Healthcare Innovations Fund, L.P.Director, 10% Owner, * Director by Deputization
Tickers
Addresses
business
THREE BALA PLAZA EAST. SUITE 506
BALA CYNWYD, PA, 19004
mailing
THREE BALA PLAZA EAST. SUITE 506
BALA CYNWYD, PA, 19004
Former Names
- ZAFGEN, INC.2020-05-19
- ZAFGEN INC2008-11-03